Rida reminds of a suit that I bought once that I wasn't sure I liked, but eventually, it turned out to be ok.
I'm thinking the market will see it that way.
Ponatinib and 113 (likin' that criz data) will eventually drive this company to new heights. It will be a bit of bumpy, but not rough, air until then.
I wonder how shorty is taking this news. This is likely the worst of it and we'll play in the 8's for a while until ASCO. Some may cover, built in hedging for the longs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.